In pancreatic cancer, EZH2 overexpression is associated with advanced stages (stage III/IV), and EZH2 knockdown promotes the reduction of proliferation, migration, and invasion (Ma et al., 2018[35]). The gene discussed is EZH2; the disease is pancreatic neoplasm.